News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Christophe Deroose: Launch of the Belgian Radiology and therapy action plan
Photo from Christophe Deroose/X
Jun 23, 2024, 08:55

Christophe Deroose: Launch of the Belgian Radiology and therapy action plan

Christophe Deroose, UZ Leuven, posted on X:

“Very grateful and proud to have participated in the launch of the Belgian Radiology and therapy action plan. We anticipate a large number of new RLT molecules in the future. With this plan, we want to be ready to get them to the patients!”

Source: Christophe Deroose/X

Belgium cancer Christophe Deroose OncoDaily Oncology Radiology and therapy RLT molecules UZ Leuven
Special Coverage
Cancer Types
Mar 30, 2025, 14:01
Melanoma (Skin Cancer): Symptoms, Causes, Stages, Diagnosis and Treatment
Science
Mar 30, 2025, 13:55
Aaron Goodman: How I use maintenance therapy in AML
Blog
Mar 30, 2025, 13:54
Carolina Reduzzi: The Liquid Biopsy Platform is launching a new seminar series within the HemOnc Seminar Talk
Cancer Types
Mar 30, 2025, 13:48
Testicular Cancer: Early Signs, Stages, Causes, Symptoms,Diagnosis, and Latest Research in 2025
Blog
Mar 30, 2025, 13:41
Yan Leyfman: Advancing CAR-T Therapy for Solid Tumors
Science
Mar 30, 2025, 13:32
Myeloma Paper of the Day, March 30th, suggested by Robert Orlowski
Blog
Mar 30, 2025, 13:24
CPOEM Foundation - Thrilled to share the recording of ASCO-Endorsed CPOEM Foundation Webinar
Blog
Mar 30, 2025, 13:06
Karine Tawagi: Pluvicto FDA Approval for Use Pre-Chemotherapy in Prostate Cancer Based on PSMAfore Trial
Blog
Mar 30, 2025, 12:49
Overcoming Stage IV Melanoma with Innovative Treatment and Expert Care - SCRI
Blog
Mar 30, 2025, 12:34
Ross Upton: External Validation of AI for Detecting Heart Failure with Preserved Ejection Fraction
Blog
Mar 30, 2025, 12:14
Amol Akhade: Will Laura trial show OS benifit at 60 % maturity?
Blog
Mar 30, 2025, 12:12
Paolo A. Ascierto: Microbiota and immunotherapy - the new frontiers for the treatment of melanoma